Date
| Title
|
| 04-18-07 | Impact
of depression and disability on quality of life in Iranian patients
with multiple sclerosis. |
| 04-19-07 | Production
of brain-derived neurotrophic factor by mononuclear cells of patients
with multiple sclerosis treated with glatiramer acetate,
interferon-beta 1a, and high doses of immunoglobulins. |
| 04-19-07 | Clinical
and laboratory features of neuromyelitis optica with oligoclonal IgG
bands. |
| 04-19-07 | Predicting
beta-interferon failure in relapsing-remitting multiple sclerosis. |
| 04-19-07 | An
exploratory study on interferon beta dose effect in reducing size of
enhancing lesions in multiple sclerosis. |
| 04-19-07 | http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17439904&itool=pubmed_DocSum
|
| 04-19-07 | Fampridine-SR
in multiple sclerosis: a randomized, double-blind, placebo-controlled,
dose-ranging study. |
| 04-19-07 | Studies
of associations between disability in multiple sclerosis, skin type,
gender and ultraviolet radiation. |
| 04-19-07 | Ginkgo
biloba for the improvement of cognitive performance in multiple
sclerosis: a randomized, placebo-controlled trial. |
| 04-19-07 | Health-related
quality of life in secondary progressive multiple sclerosis. |
| 04-19-07 | Coping
and quality of life in one hundred and thirty five subjects with
multiple sclerosis. |
| 04-19-07 | The
Faces Symbol Test, a newly developed screening instrument to assess
cognitive decline related to multiple sclerosis: first results of the
Berlin Multi-Centre FST Validation Study. |
| 04-19-07 | Caregiver
quality of life in multiple sclerosis: a multicentre Italian study. |
| 04-19-07 | Correlations
between Epstein-Barr virus antibody levels and risk factors for
multiple sclerosis in healthy individuals. |
| 04-19-07 | Arg113His
mutation of vanishing white matter is not present in multiple
sclerosis. |
| 04-19-07 | Subtle
upper limb impairment in asymptomatic multiple sclerosis subjects. |
| 04-19-07 | Kinematic
analysis of thalamic versus subthalamic neurostimulation in postural
and intention tremor. |
| 04-19-07 | Heterogeneity
of aquaporin-4 autoimmunity and spinal cord lesions in multiple
sclerosis in Japanese. |
| 04-19-07 | Efficacy
of various intravenous immunoglobulin therapy protocols in autoimmune
and chronic inflammatory disorders. |
| 04-19-07 | Nerve
fibre layer analysis with GDx with a variable corneal compensator in
patients with multiple sclerosis. |
| 04-18-07 | Dental
amalgam and multiple sclerosis: a systematic review and meta-analysis. |
| 04-18-07 | Contrasting
potential of nitric oxide and peroxynitrite to mediate oligodendrocyte
injury in multiple sclerosis. |
| 04-18-07 | Clustering
of Inflammatory Bowel Disease With Immune Mediated Diseases Among
Members of a Northern California-Managed Care Organization. |
| 04-18-07 | Plasma
lipid peroxidation and progression of disability in multiple sclerosis.
|
| 04-18-07 | High
prevalence of restless legs syndrome in multiple sclerosis. |
| 04-18-07 | Glutathione-S-transferase
T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis:
a pilot study. |
| 04-18-07 | White
matter changes in Leber's hereditary optic neuropathy: MRI findings. |
| 04-18-07 | Meningeal
B-cell follicles in secondary progressive multiple sclerosis associate
with early onset of disease and severe cortical pathology. |
| 04-18-07 | Natalizumab
reduces visual loss in patients with relapsing multiple sclerosis. |
| 04-18-07 | Steroid-responsive
neurologic relapses in a child with a proteolipid protein-1 mutation. |
| 04-18-07 | Differential
diagnosis and evaluation in pediatric multiple sclerosis. |
| 04-18-07 | Acute
disseminated encephalomyelitis. |
| 04-18-07 | Pediatric
multiple sclerosis: a short history of a long story. |
| 04-18-07 | Clinical
features of children and adolescents with multiple sclerosis. |
| 04-18-07 | MRI
features of pediatric multiple sclerosis. |
| 04-18-07 | Treatment
of pediatric multiple sclerosis and variants. |
| 04-18-07 | The
psychosocial consequences of pediatric multiple sclerosis. |
| 04-18-07 | Consensus
definitions proposed for pediatric multiple sclerosis and related
disorders. |
| 04-18-07 | Challenges
in the classification of pediatric multiple sclerosis and future
directions. |
| 04-17-07 | Epidemiology
of multiple sclerosis in Japanese: with special reference to
opticopsinal multiple sclerosis |
| 04-17-07 | Laboratory
findings in optic-spinal multiple sclerosis |
| 04-17-04 | Thrombotic
microangiopathy |
| 04-17-07 | In
vivo monitoring the fate of Cy5.5-Tat labeled T lymphocytes by
quantitative near-infrared fluorescence imaging during acute brain
inflammation in a rat model of experimental autoimmune
encephalomyelitis. |
| 04-17-07 | Therapeutic
use of dextromethorphan: Key learnings from treatment of pseudobulbar
affect. |
| 04-17-07 | Natalizumab
treatment for multiple sclerosis: recommendations for patient selection
and monitoring. |
| 04-17-07 | p150/95
(CD11c/CD18) Expression Is Required for the Development of Experimental
Autoimmune Encephalomyelitis. |
| 04-17-07 | Enolase and Arrestin are Novel
Nonmyelin Autoantigens in Multiple Sclerosis. |
| 04-14-07
| The
cost of multiple sclerosis in Australia |
| 04-14-07
| Post-deep
brain stimulation - gradual non-stimulation dependent decrease in
strength with attenuation of multiple sclerosis tremor
|
| 04-14-07
| Investigation
of TGFB2 as a candidate gene in multiple sclerosis and Parkinson's
disease |
| 04-13-07 |
Imaging
correlates of axonal swelling in chronic multiple sclerosis brains.
|
| 04-13-07
| Differential
Outcome of Tolerance Induction in Naive vs. Activated Theiler's Virus
Epitope-Specific CD8+ Cytotoxic T Cells. |
| 04-12-07
| CCR2
Regulates Development of Theiler's Murine Encephalomyelitis
Virus-Induced Demyelinating Disease. |
| 04-12-07
| Measuring
brain atrophy in multiple sclerosis. |
| 04-12-07
| Statistical
issues related to the use of MRI data in multiple sclerosis.
|
| 04-12-07
| Hughes
syndrome: the antiphospholipid syndrome-a clinical overview.
|
| 04-12-07
| Effect
of immunomodulation with human interferon-beta on early functional
recovery from experimental spinal cord injury |
| 04-12-07
| Involuntary
emotional expression disorder: treating the untreated.
|
| 04-12-07
| Vitamin
D levels in people with multiple sclerosis and community controls in
Tasmania, Australia. |
| 04-12-07 |
Motor
reorganization in multiple sclerosis. |
| 04-12-07
| The
spectrum of neuromyelitis optica: a case of NMO with extensive brain
stem involvement |
| 04-11-07 |
Physiological
basis of fatigue |
| 04-11-07
| Genetics
in multiple sclerosis: past and future perspectives
|
| 04-11-07
| Immunomodulatory
treatment of multiple sclerosis in Norway.
|
| 04-11-07
| Exploring
barriers to remaining physically active: a case report of a person with
multiple sclerosis |
| 04-11-07
| Beta-interferon
unbalances the peripheral T cell proinflammatory response in
experimental autoimmune encephalomyelitis
|
| 04-11-07
| The
impact of neuropathic pain on health-related quality of life: review
and implications |
| 04-11-07
| The
role of hereditary spastic paraplegia related genes in multiple
sclerosis : A study of disease susceptibility and clinical outcome
|
| 04-11-07
| Pharmacodynamics
of interferon beta in multiple sclerosis patients with or without serum
neutralizing antibodies |
| 04-11-07
| Rehabilitation
therapy in multiple sclerosis |
| 04-08-07
| Opexa
Therapeutics Launches Tovaxin(TM) Clinical Trial Website for Multiple
Sclerosis |
| 04-07-07
| Lupoid
Sclerosis: What Is the Role of Antiphospholipid Antibodies?
|
| 04-07-07
| The
role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese
Multiple Sclerosis population. |
| 04-07-07
| A
Dinucleotide Deletion in CD24 Confers Protection against Autoimmune
Diseases |
| 04-07-07 |
Analysis
of NAMCS data for Multiple Sclerosis, 1998-2004.
|
| 04-07-07
| Immunization
With Neurofilament Light Protein Induces Spastic Paresis and Axonal
Degeneration in Biozzi ABH Mice. |
| 04-07-07
| The
Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions.
|
| 04-07-07
| Rethinking
neuromyelitis optica (devic disease). |
| 04-07-07
| Kinesigenic
paroxysmal hemidyskinesia as the initial presentation of multiple
sclerosis. |
| 04-07-07 |
N-acetylaspartic
acid in cerebrospinal fluid of multiple sclerosis patients determined
by gas-chromatography-mass spectrometry. |
| 04-04-07
| The
endocannabinoid system and neurogenesis in health and disease.
|
| 04-04-07
| Fatigue
in neurological disease: different patterns in stroke and multiple
sclerosis |
| 04-01-07 |
Astrocytic
activation in relation to inflammatory markers during clinical
exacerbation of relapsing-remitting multiple sclerosis.
|
| 04-01-07
| Glucocorticoid
receptor gene polymorphisms associated with more aggressive disease
phenotype in MS |
| 04-01-07
| Natalizumab:
Overview of Its Pharmacology and Safety.
|
| 04-01-07
| Molecular
dynamics at the receptor level of immunodominant myelin basic protein
epitope 87-99 implicated
in multiple sclerosis and its antagonists altered peptide ligands:
Triggering of immune response.
|
| 04-01-07
| Pharmacokinetics
and pharmacodynamics of the interferon-betas, glatiramer acetate, and
mitoxantrone in multiple sclerosis. |
